📢 #IBD practices - are you looking to add or optimize the role of #pharmacist on your team? ✅ below for information on what services IBD pharmacists provide and how to justify the addition of one on your team! Florian Rieder Miguel Regueiro IBDJournal & CC360 pubmed.ncbi.nlm.nih.gov/37650888/

Big news in the IBD world as results from yet another biologic head to head trial were released. This time it was risankizumab compared to ustekinumab. Risankizumab met both primary endpoints of non-inferiority in clinical remission. Check it out below. prnewswire.com/news-releases/…

Celebrating some of our favorite women pharmacists today and every day!

Velsipity (Etrasimod) if now FDA approved for ulcerative colitis! #gitwitter #IBD

Thank you Crohn's & Colitis Foundation and Eugene Yen for supporting IBD pharmacists for education! We had an amazing IBD pharmacist break out education. #GITwitter #IBD #ibdpharmacistnetwork

What an exciting time for IBD with all these new therapies! Mirikizumab (Omvoh) is FDA Approved for Ulcerative colitis!! #GItwitter #IBD prnewswire.com/news-releases/…

Major update! Subcutaneous infliximab-dyyb has been approved for the maintenance treatment of Crohn's disease and ulcerative colitis. Subcutaneous infliximab-dyyb should be started after completion of IV infusion induction therapy. pharmacytimes.com/view/fda-appro…

Excited for next week’s Crohn’s and Colitis Congress. Fellow pharmacists, who is planning to be in Vegas? #CCCongress24

sciencedirect.com/science/articl… Vonoprazan has been FDA approved for the treatment and maintenance of erosive esophagitis based on a phase 3 trial demonstrating superiority vs. lansoprazole. Superiority was driven by patients with more severe disease.

Upadacitinib for acute severe UC • n is 25 • strange %'s in abstract • AJG - The American Journal of Gastroenterology website down Peter Higgins can you share ms please

Had an amazing experience at #CCCongress24 in Las Vegas! Great job IBD pharmacists. Going to make waves in patient care!

“I think it’s really exciting in the #IBD space right now because our arsenal of tools 🛠️ is going to continue to grow,” David Choi, PharmD said at #CCCongress24. Check it out ⬇️ healio.com/news/gastroent…

Dr. Satish Rao shares AGA guidelines for IBS: 🚫 Routine stool testing & colonoscopy <45 yrs 🎯 Positive diagnostic strategy recommended 💡 Recommend celiac serologies, CRP, fecal calprotectin, anorectal physiology testing GUILD Conference

Ribosome profiling (Ribo-Seq) has played a key role in discovering functional smORFs and microproteins, but its effectiveness can still be improved. One way to enhance this method is by integrating proteogenomics, which my lab colleague did here: nature.com/articles/s4146…

Tremfya is FDA approved for Crohn's disease! This has both IV (200 mg) and subq (400 mg) induction loading dose options followed by subq maintenance dose (100 mg or 200 mg). #GITwitter #IBD jnj.com/media-center/p…

U.S. FDA approves TREMFYA® (guselkumab), the first and only IL-23 inhibitor offering both subcutaneous and intravenous induction options, for adult patients with moderately to severely active Crohn’s disease #Crohns #guselkumab jnj.com/media-center/p…

Relative potency of PPIs 💊😅

Excited to contribute to this issue to highlight the role of #pharmacists in #GI care!

IBD Treatment 101 was an awesome session. It approachable to those that are just entering the field and applicable even for folks who have taught or treated IBD patients for awhile. Also a huge shoutout to David Choi, PharmD and Shubha Bhat, PharmD for repping pharmacists.